Simultaneously, glucagon receptor activation in hepatocytes stimulates glycogenolysis, gluconeogenesis, lipid oxidation, and thermogenesis, increasing total energy expenditure and directly reducing hepatic steatosis
Slow titration of dose can help, as can dietary adjustments. The recent mast cell paper suggested: significantly lower doses of GLP-1RAs than presently used as starting doses for T2DM and obesity therapy might be sufficient, and even optimal, for MCAS
Its like the whole prebiotic story
Arch Med Res 52(1):2537 Vachliotis I, Goulas A, Papaioannidou P, Polyzos SA (2022) Nonalcoholic fatty liver disease: lifestyle and quality of life
LC-MS/MS was also applied in another semaglutide pharmacokinetics study conducted on both healthy subjects and those with type 2 diabetes [79]